Protagonist Therapeutics Inc (PTGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PTGX? Forum Prognose

Finanzdaten der Protagonist Therapeutics Inc-Aktie (PTGX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	57.83% 7.437	4.712	5.546	28.32	4.675
Operating Expenses	13.02% 57.79	51.13	47.59	47.63	46.13
Benefits Costs and Expenses	16.13% 51.16	44.05	40.15	39.98	38.30
Costs And Expenses	16.13% 51.16	44.05	40.15	39.98	38.30
Operating Income/Loss	8.47% -50.35	-46.42	-42.04	-19.31	-41.45
Income/Loss From Continuing Operations Before Tax	11.13% -43.72	-39.34	-34.60	-11.65	-33.63
Income Tax Expense/Benefit	0.666	-	0.172	-	-0.42
Income/Loss From Continuing Operations After Tax	12.82% -44.38	-39.34	-34.77	-11.65	-33.21
Net Income/Loss	12.82% -44.38	-39.34	-34.77	-11.65	-33.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.76% 0.1545	63.77	63.51	62.96	61.77
Diluted Average Shares	99.76% 0.1545	63.77	63.51	62.96	61.77
Basic Earnings Per Share	12.90% -0.70	-0.62	-0.55	-0.19	-0.54
Diluted Earnings Per Share	12.90% -0.70	-0.62	-0.55	-0.19	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-